You are here

Sarcoma

Globally, the incidence of sarcoma in young adults is approximately 2/100,000 persons with a greater incidence in males over females by a 2:1 ratio. Previous radiation and chemotherapy exposure before the age of 20, as well as exposure to certain chemical agents, has been linked to an increased risk in the development of sarcoma in the young adult population. Young adult sarcoma patients seem to do worse then their pediatric counterparts for a variety of reasons, one being the differences in the biology of their cancers. These differences in biology need to be accounted for when establishing treatment plans in this age group in determining pediatric- versus adult-based protocols.

Source: Soliman H, Ferrari A, Thomas D. Sarcoma in the Young Adult Population: An International View. Semin Oncol. 2009; 36:227-236.

SeventyK Tips 4 Life

TipText: 
AYA patients are less likely to enroll in clinical trials than children or adults due to inadequate health insurance, lack of referrals and many clinicians don’t know of AYA trials. AYA participation is crucial to finding effective therapies. Many comprehensive cancer centers, university med centers, and pediatric centers- support AYA trials.

Get More Tips 4 Life >>

from patients, caregivers and medical professionals dealing with this disease and many other diseases

Powered by My Bridge 4 Life